Clinical features and post-surgical outcome of patients with astroblastoma

Michael E. Sughrue, Jay Choi, Martin J. Rutkowski, Derick Aranda, Ari J. Kane, Igor J. Barani, Andrew T. Parsa

Research output: Contribution to journalReview article

Abstract

Astroblastoma is a rare tumor, and thus experience with these lesions is very limited. The prognosis and appropriate treatment is not well understood, as few individual centers have enough experience with astroblastoma to guide treatment recommendations. We performed a systematic comprehensive search of the published English language literature on patients undergoing surgery for astroblastoma to summarize what is known about these tumors, and to provide some framework for future efforts in this area. A total of 62 references met our inclusion criteria, and contained individual patient data on 116 patients with astroblastoma. Determination of overall survival rates was performed using Kaplan-Meier analysis. This analysis suggests that the distribution is bimodal, with a prominent peak in young adulthood. Astroblastomas are generally amenable to complete tumor resection, even when very large, with gross total resection (GTR) achieved in 71/85 (84%) of reported patients, including both 9 cm tumors reported. Patients undergoing GTR experienced a significant improvement in survival compared to patients who underwent subtotal resection (STR) (5-year progression-free survival: GTR 83% versus [vs.] STR 55%, log rank p = 0.011). Although patients receiving external beam radiotherapy or fractionated three-dimensional conformal radiotherapy (XRT) seemed to have lower survival rates, this was not statistically significant (5-year survival: GTR 94% vs. GTR + XRT 73%, log rank p = 0.463). Thus, we have reported the results of a summary of the literature on astroblastomas and have accurately described outcome characteristics using a data set that would be difficult to accumulate at a single center treating this tumor.

Original languageEnglish (US)
Pages (from-to)750-754
Number of pages5
JournalJournal of Clinical Neuroscience
Volume18
Issue number6
DOIs
StatePublished - Jun 1 2011
Externally publishedYes

Fingerprint

Neuroepithelial Neoplasms
Neoplasms
Survival Rate
Conformal Radiotherapy
Survival
Kaplan-Meier Estimate
Disease-Free Survival
Language
Radiotherapy
Therapeutics

Keywords

  • Astroblastoma
  • Gross total resection
  • Radiotherapy
  • Surgery
  • Tumor control

ASJC Scopus subject areas

  • Surgery
  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Sughrue, M. E., Choi, J., Rutkowski, M. J., Aranda, D., Kane, A. J., Barani, I. J., & Parsa, A. T. (2011). Clinical features and post-surgical outcome of patients with astroblastoma. Journal of Clinical Neuroscience, 18(6), 750-754. https://doi.org/10.1016/j.jocn.2010.11.007

Clinical features and post-surgical outcome of patients with astroblastoma. / Sughrue, Michael E.; Choi, Jay; Rutkowski, Martin J.; Aranda, Derick; Kane, Ari J.; Barani, Igor J.; Parsa, Andrew T.

In: Journal of Clinical Neuroscience, Vol. 18, No. 6, 01.06.2011, p. 750-754.

Research output: Contribution to journalReview article

Sughrue, ME, Choi, J, Rutkowski, MJ, Aranda, D, Kane, AJ, Barani, IJ & Parsa, AT 2011, 'Clinical features and post-surgical outcome of patients with astroblastoma', Journal of Clinical Neuroscience, vol. 18, no. 6, pp. 750-754. https://doi.org/10.1016/j.jocn.2010.11.007
Sughrue ME, Choi J, Rutkowski MJ, Aranda D, Kane AJ, Barani IJ et al. Clinical features and post-surgical outcome of patients with astroblastoma. Journal of Clinical Neuroscience. 2011 Jun 1;18(6):750-754. https://doi.org/10.1016/j.jocn.2010.11.007
Sughrue, Michael E. ; Choi, Jay ; Rutkowski, Martin J. ; Aranda, Derick ; Kane, Ari J. ; Barani, Igor J. ; Parsa, Andrew T. / Clinical features and post-surgical outcome of patients with astroblastoma. In: Journal of Clinical Neuroscience. 2011 ; Vol. 18, No. 6. pp. 750-754.
@article{5b25938fd7bf44cb8c5f8c12ca3bb2b2,
title = "Clinical features and post-surgical outcome of patients with astroblastoma",
abstract = "Astroblastoma is a rare tumor, and thus experience with these lesions is very limited. The prognosis and appropriate treatment is not well understood, as few individual centers have enough experience with astroblastoma to guide treatment recommendations. We performed a systematic comprehensive search of the published English language literature on patients undergoing surgery for astroblastoma to summarize what is known about these tumors, and to provide some framework for future efforts in this area. A total of 62 references met our inclusion criteria, and contained individual patient data on 116 patients with astroblastoma. Determination of overall survival rates was performed using Kaplan-Meier analysis. This analysis suggests that the distribution is bimodal, with a prominent peak in young adulthood. Astroblastomas are generally amenable to complete tumor resection, even when very large, with gross total resection (GTR) achieved in 71/85 (84{\%}) of reported patients, including both 9 cm tumors reported. Patients undergoing GTR experienced a significant improvement in survival compared to patients who underwent subtotal resection (STR) (5-year progression-free survival: GTR 83{\%} versus [vs.] STR 55{\%}, log rank p = 0.011). Although patients receiving external beam radiotherapy or fractionated three-dimensional conformal radiotherapy (XRT) seemed to have lower survival rates, this was not statistically significant (5-year survival: GTR 94{\%} vs. GTR + XRT 73{\%}, log rank p = 0.463). Thus, we have reported the results of a summary of the literature on astroblastomas and have accurately described outcome characteristics using a data set that would be difficult to accumulate at a single center treating this tumor.",
keywords = "Astroblastoma, Gross total resection, Radiotherapy, Surgery, Tumor control",
author = "Sughrue, {Michael E.} and Jay Choi and Rutkowski, {Martin J.} and Derick Aranda and Kane, {Ari J.} and Barani, {Igor J.} and Parsa, {Andrew T.}",
year = "2011",
month = "6",
day = "1",
doi = "10.1016/j.jocn.2010.11.007",
language = "English (US)",
volume = "18",
pages = "750--754",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",
number = "6",

}

TY - JOUR

T1 - Clinical features and post-surgical outcome of patients with astroblastoma

AU - Sughrue, Michael E.

AU - Choi, Jay

AU - Rutkowski, Martin J.

AU - Aranda, Derick

AU - Kane, Ari J.

AU - Barani, Igor J.

AU - Parsa, Andrew T.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Astroblastoma is a rare tumor, and thus experience with these lesions is very limited. The prognosis and appropriate treatment is not well understood, as few individual centers have enough experience with astroblastoma to guide treatment recommendations. We performed a systematic comprehensive search of the published English language literature on patients undergoing surgery for astroblastoma to summarize what is known about these tumors, and to provide some framework for future efforts in this area. A total of 62 references met our inclusion criteria, and contained individual patient data on 116 patients with astroblastoma. Determination of overall survival rates was performed using Kaplan-Meier analysis. This analysis suggests that the distribution is bimodal, with a prominent peak in young adulthood. Astroblastomas are generally amenable to complete tumor resection, even when very large, with gross total resection (GTR) achieved in 71/85 (84%) of reported patients, including both 9 cm tumors reported. Patients undergoing GTR experienced a significant improvement in survival compared to patients who underwent subtotal resection (STR) (5-year progression-free survival: GTR 83% versus [vs.] STR 55%, log rank p = 0.011). Although patients receiving external beam radiotherapy or fractionated three-dimensional conformal radiotherapy (XRT) seemed to have lower survival rates, this was not statistically significant (5-year survival: GTR 94% vs. GTR + XRT 73%, log rank p = 0.463). Thus, we have reported the results of a summary of the literature on astroblastomas and have accurately described outcome characteristics using a data set that would be difficult to accumulate at a single center treating this tumor.

AB - Astroblastoma is a rare tumor, and thus experience with these lesions is very limited. The prognosis and appropriate treatment is not well understood, as few individual centers have enough experience with astroblastoma to guide treatment recommendations. We performed a systematic comprehensive search of the published English language literature on patients undergoing surgery for astroblastoma to summarize what is known about these tumors, and to provide some framework for future efforts in this area. A total of 62 references met our inclusion criteria, and contained individual patient data on 116 patients with astroblastoma. Determination of overall survival rates was performed using Kaplan-Meier analysis. This analysis suggests that the distribution is bimodal, with a prominent peak in young adulthood. Astroblastomas are generally amenable to complete tumor resection, even when very large, with gross total resection (GTR) achieved in 71/85 (84%) of reported patients, including both 9 cm tumors reported. Patients undergoing GTR experienced a significant improvement in survival compared to patients who underwent subtotal resection (STR) (5-year progression-free survival: GTR 83% versus [vs.] STR 55%, log rank p = 0.011). Although patients receiving external beam radiotherapy or fractionated three-dimensional conformal radiotherapy (XRT) seemed to have lower survival rates, this was not statistically significant (5-year survival: GTR 94% vs. GTR + XRT 73%, log rank p = 0.463). Thus, we have reported the results of a summary of the literature on astroblastomas and have accurately described outcome characteristics using a data set that would be difficult to accumulate at a single center treating this tumor.

KW - Astroblastoma

KW - Gross total resection

KW - Radiotherapy

KW - Surgery

KW - Tumor control

UR - http://www.scopus.com/inward/record.url?scp=79955883062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955883062&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2010.11.007

DO - 10.1016/j.jocn.2010.11.007

M3 - Review article

C2 - 21507653

AN - SCOPUS:79955883062

VL - 18

SP - 750

EP - 754

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

IS - 6

ER -